Moderna Inc said on Wednesday it had initiated submission of data to the US Food and Drug Administration (FDA) for the evaluation of a booster dose of its COVID-19 vaccine.
Moderna submits initial data for COVID vaccine booster to US FDA
By REUTERS
11/05/2024 01:08 PM
By REUTERS
11/05/2024 12:33 PM
By REUTERS
11/05/2024 12:31 PM
By REUTERS
11/05/2024 12:22 PM
By AVI ASHKENAZI
11/05/2024 11:34 AM
By REUTERS
11/05/2024 11:15 AM
By REUTERS
11/05/2024 10:54 AM
By REUTERS
11/05/2024 10:14 AM
By REUTERS
11/05/2024 01:17 AM
By REUTERS
11/05/2024 01:02 AM